Disc Medicine (IRON)

Disc Medicine on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

Short interest in Disc Medicine (IRON) was 6.9 million shares at the 30 October 2026 settlement, down 8.0% from the 15 October 2026 settlement, with days to cover at 3.2. In the last 90 days Disc Medicine insiders reported 28 open-market sales and no purchases, net sales of $11.9 million. The largest was a sale of 26,542 shares worth $2.1 million by Bitterman Kevin (Director) on 2 September 2026. The next earnings report for Disc Medicine is estimated for 11 January 2027.

6.9M

Short interest

settlement 2026-10-30

3.2

Days to cover

-7.5 days vs prior

52.9%

Short share of volume

2026-11-20

12,952

Fails to deliver

settlement 2026-10-30

Mon 11 Jan

Next earnings

estimated date

-$11.9M

Insider flow, 90 days

0 buys, 28 sells

As of 2026-11-20.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 October 2026, short interest in IRON is 6,862,594 shares, down 407,826 shares over the last month. Over the last 48 readings it ranged from 1,628,477 shares (29 November 2024) to 7,457,523 shares (15 October 2026). At the reported average volume of 2.2M shares a day that is 3.2 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/iron" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-306,862,594-8.0%2,159,3773.18
2026-10-157,457,523+2.6%701,30110.63
2026-09-307,270,420+0.9%568,31712.79
2026-09-157,207,702-2.1%528,93213.63
2026-08-317,365,002+0.3%442,81016.63
2026-08-147,342,568-0.7%295,88924.82
2026-07-317,394,606+1.4%353,40120.92
2026-07-157,290,442+14.6%675,78310.79
2026-06-306,363,314+5.9%995,1806.39
2026-06-156,010,116+0.2%427,10814.07
2026-05-295,999,027+5.8%411,19714.59
2026-05-155,668,145+2.3%537,28910.55
2026-04-305,538,727+5.7%355,54115.58
2026-04-155,241,636-4.0%421,82512.43
2026-03-315,460,074+21.4%574,4619.50
2026-03-134,496,970+5.3%581,9897.73
2026-02-274,269,919+25.1%1,046,5544.08
2026-02-133,412,711-16.8%874,1423.90
2026-01-304,100,690-4.2%473,6858.66
2026-01-154,281,868+13.0%563,6357.60
2025-12-313,790,158+53.8%785,5104.83
2025-12-152,464,343-4.7%476,4715.17
2025-11-282,586,932-14.2%677,1883.82
2025-11-143,015,866+5.2%430,3597.01
2025-10-312,867,219+6.4%716,5004.00
2025-10-152,693,868+2.1%398,7506.76
2025-09-302,638,649+17.9%376,0597.02
2025-09-152,237,016+6.4%338,1976.61
2025-08-292,102,467-13.6%231,9419.06
2025-08-152,431,864+7.7%373,5226.51
2025-07-312,259,068-20.2%395,0455.72
2025-07-152,831,428-7.7%280,50710.09
2025-06-303,068,367-4.3%428,1297.17
2025-06-133,204,802+3.5%428,2897.48
2025-05-303,096,277-4.2%305,09210.15
2025-05-153,231,435+0.6%395,0878.18
2025-04-303,212,366+17.5%353,4559.09
2025-04-152,733,628+13.1%725,8963.77
2025-03-312,417,318+8.1%397,3696.08
2025-03-142,235,716-3.7%338,1346.61
2025-02-282,321,289-6.4%346,6946.70
2025-02-142,478,863+14.0%284,5078.71
2025-01-312,174,591+6.4%555,9613.91
2025-01-152,043,718+15.4%345,8405.91
2024-12-311,770,940+6.7%207,1488.55
2024-12-131,660,569+2.0%238,9756.95
2024-11-291,628,477-0.9%279,3215.83
2024-11-151,643,231+1.0%544,1953.02

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 20 November 2026, the short share of IRON volume is 52.9%, down 5.1 points over the last five sessions. Over the last 30 readings it ranged from 27.0% (6 November 2026) to 80.8% (16 October 2026). The latest reading is 3.9 points above the 30-session average of 49.0%, on 206K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-20109K206K52.9%1
2026-11-1969K177K39.1%1
2026-11-18134K281K47.5%0
2026-11-1782K167K49.2%0
2026-11-16167K335K49.7%10
2026-11-13140K241K58.1%0
2026-11-12205K315K65.2%0
2026-11-11100K186K53.7%0
2026-11-10324K875K37.0%2,366
2026-11-09101K300K33.6%0
2026-11-0674K274K27.0%0
2026-11-05107K293K36.7%0
2026-11-0481K232K34.8%20
2026-11-03121K269K44.9%0
2026-11-0265K165K39.6%29
2026-10-30116K214K54.1%5
2026-10-2998K220K44.4%0
2026-10-28140K281K49.6%796
2026-10-27206K514K40.1%1,000
2026-10-26138K320K43.2%1,500
2026-10-23177K399K44.5%1,400
2026-10-22261K505K51.7%49
2026-10-21721K1.8M40.0%0
2026-10-20397K967K41.1%238
2026-10-191.8M3.4M54.1%5,868
2026-10-16160K198K80.8%0
2026-10-15130K240K54.1%35
2026-10-14103K159K64.5%0
2026-10-13175K229K76.3%0
2026-10-12131K204K64.2%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 30 October 2026, the fails-to-deliver balance in IRON is 12,952 shares, up 12,652 shares over the last settlement date. Over the last 30 readings it ranged from 7 shares (22 May 2026) to 256,969 shares (2 July 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-3012,952$82.84$1.1M
2026-10-28300$79.90$24K
2026-10-2268$76.00$5K
2026-10-21541$79.48$43K
2026-10-2020,075$78.93$1.6M
2026-10-157$55.74$390
2026-10-13643$60.48$39K
2026-09-1411,956$70.06$838K
2026-08-2148$78.84$4K
2026-08-14498$80.01$40K
2026-08-11845$78.28$66K
2026-08-0350$77.00$4K
2026-07-3114$79.21$1K
2026-07-22133$75.58$10K
2026-07-21564$74.38$42K
2026-07-2026$76.15$2K
2026-07-02256,969$74.95$19.3M
2026-06-30148$74.50$11K
2026-06-2917,517$74.78$1.3M
2026-06-2273,695$70.79$5.2M
2026-06-151,326$67.99$90K
2026-06-1213$68.08$885
2026-06-101,390$68.34$95K
2026-06-041,767$70.35$124K
2026-06-0363$68.00$4K
2026-06-022,957$71.97$213K
2026-05-281,675$69.76$117K
2026-05-271,065$68.12$73K
2026-05-261,449$66.82$97K
2026-05-227$67.13$470

Insider trades

SEC Form 4, newest first. JSON

Insiders at IRON reported 28 open-market sells worth $11.9M in the last 90 days and no open-market buys. Latest filing: Savage William Jacob (Chief Medical Officer) on 2026-11-10.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-11-10Savage William JacobChief Medical OfficerSell16K$85.09$1.4M63K
2026-10-21Bitterman KevinDirectorSell266$80.23$21K13K
2026-10-21Bitterman KevinDirectorSell11K$80.23$920K293K
2026-10-21Bitterman KevinDirectorSell14K$80.23$1.1M296K
2026-10-20Bitterman KevinDirectorSell55$79.95$4K13K
2026-10-20Bitterman KevinDirectorSell2K$79.95$191K305K
2026-10-20Bitterman KevinDirectorSell3K$79.95$229K310K
2026-10-19Bitterman KevinDirectorSell115$79.97$9K13K
2026-10-19Bitterman KevinDirectorSell5K$79.97$395K307K
2026-10-19Bitterman KevinDirectorSell6K$79.97$475K313K
2026-09-15Quisel John DChief Executive OfficerExercise or conversion36K$1.01$36K262K
2026-09-11Bitterman KevinDirectorExercise or conversion10K$50.86$509K27K
2026-09-11Bitterman KevinDirectorSell27K$70.11$1.9M0
2026-09-11Bitterman KevinDirectorExercise or conversion10K$38.85$389K17K
2026-09-11Bitterman KevinDirectorExercise or conversion7K$45.69$326K7K
2026-09-04Bitterman KevinDirectorSell18$79.96$1K13K
2026-09-04Bitterman KevinDirectorSell759$79.96$61K312K
2026-09-04Bitterman KevinDirectorSell912$79.96$73K319K
2026-09-03Bitterman KevinDirectorSell54$79.98$4K13K
2026-09-03Bitterman KevinDirectorSell2K$79.98$187K313K
2026-09-03Bitterman KevinDirectorSell3K$79.98$225K320K
2026-09-02Bitterman KevinDirectorSell2$80.98$16213K
2026-09-02Bitterman KevinDirectorSell9$80.98$729315K
2026-09-02Bitterman KevinDirectorSell10$80.98$810323K
2026-09-02Bitterman KevinDirectorSell511$80.17$41K14K
2026-09-02Bitterman KevinDirectorSell22K$80.17$1.8M315K
2026-09-02Bitterman KevinDirectorSell27K$80.17$2.1M323K
2026-09-01Bitterman KevinDirectorSell1$79.95$8014K
2026-09-01Bitterman KevinDirectorSell58$79.95$5K337K
2026-09-01Bitterman KevinDirectorSell70$79.95$6K349K
2026-08-25Yu Jonathan Yen-WenChief Operating OfficerSell9K$83.12$731K54K
2026-08-25Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion9K$13.50$119K63K
2026-08-24Yu Jonathan Yen-WenChief Operating OfficerSell300$82.53$25K54K
2026-08-24Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion300$13.50$4K55K
2026-08-17Quisel John DChief Executive OfficerSell12K$79.84$949K226K
2026-08-17Quisel John DChief Executive OfficerSell13K$79.20$1.0M238K
2026-08-17Quisel John DChief Executive OfficerSell8K$78.11$656K251K
2026-08-17Quisel John DChief Executive OfficerExercise or conversion33K$13.50$446K259K
2026-08-12Yu Jonathan Yen-WenChief Operating OfficerSell804$82.64$66K54K
2026-08-12Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion804$13.50$11K55K
2026-08-06Khara RahulChief Legal OfficerSell5K$80.00$400K52K
2026-08-06Khara RahulChief Legal OfficerExercise or conversion5K$14.69$73K57K
2026-07-13Quisel John DChief Executive OfficerSell6K$76.05$487K226K
2026-07-13Quisel John DChief Executive OfficerSell17K$74.95$1.3M232K
2026-07-13Quisel John DChief Executive OfficerSell10K$74.27$721K249K
2026-07-13Quisel John DChief Executive OfficerExercise or conversion7K$13.50$100K259K
2026-07-13Quisel John DChief Executive OfficerExercise or conversion26K$9.86$252K252K
2026-07-07Yu Jonathan Yen-WenChief Operating OfficerSell100$82.50$8K54K
2026-07-07Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion100$13.50$1K54K
2026-06-29Khara RahulChief Legal OfficerSell2K$75.00$124K52K
2026-06-29Khara RahulChief Legal OfficerExercise or conversion2K$14.69$24K54K
2026-06-26Yu Jonathan Yen-WenChief Operating OfficerSell300$72.50$22K54K
2026-06-26Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion300$13.50$4K55K
2026-06-26Khara RahulChief Legal OfficerExercise or conversion851$14.69$13K53K
2026-06-26Khara RahulChief Legal OfficerSell851$75.00$64K52K
2026-06-22Yu Jonathan Yen-WenChief Operating OfficerSell10K$72.66$705K54K
2026-06-22Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion10K$13.50$131K64K
2026-06-18Quisel John DChief Executive OfficerSell23K$69.92$1.6M237K
2026-06-18Quisel John DChief Executive OfficerSell10K$70.70$673K228K
2026-06-18Quisel John DChief Executive OfficerSell2K$71.61$111K226K
2026-06-18Quisel John DChief Executive OfficerExercise or conversion34K$9.86$335K260K
2026-06-18Khara RahulChief Legal OfficerSell5K$69.94$378K54K
2026-06-18Khara RahulChief Legal OfficerSell2K$70.73$113K53K
2026-06-18Khara RahulChief Legal OfficerSell500$71.62$36K52K
2026-06-18Khara RahulChief Legal OfficerExercise or conversion8K$14.69$110K60K
2026-06-16Yu Jonathan Yen-WenChief Operating OfficerSell12K$68.76$801K61K
2026-06-16Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion5K$9.86$52K60K
2026-06-16Yu Jonathan Yen-WenChief Operating OfficerExercise or conversion13K$9.86$132K73K
2026-06-16Yu Jonathan Yen-WenChief Operating OfficerSell7K$69.92$487K54K
2026-04-14Franchi Jean M.Chief Financial OfficerSell6K$69.24$433K64K
2026-04-13Savage William JacobChief Medical OfficerSell2K$66.81$147K79K
2026-04-13Savage William JacobChief Medical OfficerSell4K$66.12$233K82K
2026-04-13Franchi Jean M.Chief Financial OfficerSell400$69.00$28K71K
2026-03-02Savage William JacobChief Medical OfficerSell3K$66.41$198K85K
2026-03-02Savage William JacobChief Medical OfficerSell4K$65.52$288K88K
2026-02-25Franchi Jean M.Chief Financial OfficerSell353$69.06$24K71K
2026-02-18Franchi Jean M.Chief Financial OfficerSell4K$65.89$243K71K
2026-02-18Franchi Jean M.Chief Financial OfficerSell3K$65.01$221K75K
2026-02-17Khara RahulChief Legal OfficerSell3K$62.86$179K52K
2026-02-17Stephenson PamelaChief Commercial OfficerSell6K$62.86$348K81K
2026-02-17Savage William JacobChief Medical OfficerSell3K$62.86$205K93K
2026-02-17Yu Jonathan Yen-WenChief Operating OfficerSell3K$62.86$203K54K
2026-02-17Quisel John DChief Executive OfficerSell13K$62.86$834K226K
2026-02-17Franchi Jean M.Chief Financial OfficerSell4K$62.86$256K78K
2026-02-10Khara RahulChief Legal OfficerGrant17K$0.00$055K
2026-02-10Stephenson PamelaChief Commercial OfficerGrant17K$0.00$087K
2026-02-10Savage William JacobChief Medical OfficerGrant17K$0.00$096K
2026-02-10Yu Jonathan Yen-WenChief Operating OfficerGrant17K$0.00$058K
2026-02-10Franchi Jean M.Chief Financial OfficerGrant19K$0.00$082K
2026-02-10Quisel John DChief Executive OfficerGrant55K$0.00$0239K
2026-01-20Khara RahulChief Legal OfficerSell1K$69.74$70K38K
2026-01-20Khara RahulChief Legal OfficerExercise or conversion1K$13.50$14K39K
2026-01-02Khara RahulChief Legal OfficerSell1K$79.27$92K38K
2026-01-02Khara RahulChief Legal OfficerSell5K$78.62$393K39K
2026-01-02Khara RahulChief Legal OfficerSell350$77.67$27K44K
2026-01-02Khara RahulChief Legal OfficerExercise or conversion7K$13.50$88K44K
2025-12-22Savage William JacobChief Medical OfficerExercise or conversion99$13.50$1K79K
2025-12-22Savage William JacobChief Medical OfficerExercise or conversion219$9.86$2K79K
2025-12-22Savage William JacobChief Medical OfficerExercise or conversion3K$9.86$28K79K
2025-12-19Quisel John DChief Executive OfficerExercise or conversion12K$1.01$12K184K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

50 Form 144 notices on file for IRON worth $54.5M at the prices reported; 2 in the last 90 days worth $3.2M. Latest: WILLIAM SAVAGE filed on 2026-11-10 to sell 16,035 shares ($1.3M) from 2026-11-10.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-11-10WILLIAM SAVAGEOfficer16K$1.3M0.035%2026-11-10Morgan Stanley Smith Barney LLC Executive Financial Services
2026-09-11KEVIN J BITTERMANOfficer27K$1.9M0.071%2026-09-11Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-17JOHN QUISELDirector, Officer33K$2.6M0.086%2026-08-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-06RAHUL KHARAOfficer5K$395K0.013%2026-08-06Morgan Stanley Smith Barney LLC Executive Financial Services
2026-07-13JOHN QUISELDirector, Officer33K$2.5M0.086%2026-07-13Morgan Stanley Smith Barney LLC Executive Financial Services
2026-07-07JONATHAN YUOfficer10K$770K0.026%2026-07-07Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-26RAHUL KHARAOfficer3K$175K0.007%2026-06-26Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-22JONATHAN YUOfficer10K$708K0.026%2026-06-22Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-18JOHN QUISELDirector, Officer34K$2.4M0.089%2026-06-18Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-18RAHUL KHARAOfficer8K$527K0.020%2026-06-18Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-16JONATHAN YUOfficer19K$1.3M0.049%2026-06-16Morgan Stanley Smith Barney LLC Executive Financial Services
2026-04-13WILLIAM SAVAGEOfficer6K$380K0.015%2026-04-13Morgan Stanley Smith Barney LLC Executive Financial Services
2026-03-02WILLIAM SAVAGEOfficer7K$492K0.019%2026-03-02Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-25JEAN FRANCHIOfficer7K$464K0.019%2026-02-25Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-18JEAN FRANCHIOfficer7K$464K0.019%2026-02-18Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Khara RahulOfficer3K$160K0.008%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Stephenson PamelaOfficer6K$309K0.015%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Savage William JacobOfficer3K$182K0.009%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Yu Jonathan Yen-WenOfficer3K$181K0.009%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Franchi Jean M.Officer4K$228K0.011%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17Quisel John DOfficer, Director13K$742K0.035%2026-02-17Morgan Stanley Smith Barney LLC Executive Financial Services
2026-01-02RAHUL KHARAOfficer8K$596K0.020%2026-01-02Morgan Stanley Smith Barney LLC Executive Financial Services
2025-12-17Atlas Venture Opportunity Fund II, LPShareholder213$19K0.001%2025-12-17Merrill Lynch
2025-12-17Atlas Venture Opportunity Fund I, LPShareholder393$36K0.001%2025-12-17Merrill Lynch
2025-12-17Atlas Venture Fund XII, LPShareholder148$14K0.000%2025-12-17Merrill Lynch
2025-12-17Atlas Venture Fund X, LPShareholder818$75K0.002%2025-12-17Merrill Lynch
2025-12-17AI DMI LLCAffiliate50$4K0.000%2025-12-17Tourmaline Partners, LLC
2025-12-16Atlas Venture Opportunity Fund II, LPShareholder6K$521K0.015%2025-12-16Merrill Lynch
2025-12-16Atlas Venture Opportunity Fund II, L.P.Shareholder13K$1.2M0.034%2025-12-16BTIG, LLC
2025-12-16Atlas Venture Opportunity Fund I, LPShareholder11K$1.0M0.029%2025-12-16Merrill Lynch
2025-12-16Atlas Venture Opportunity Fund I, L.P.Shareholder25K$2.3M0.066%2025-12-16BTIG, LLC
2025-12-16Atlas Venture Fund XII, LPShareholder4K$401K0.012%2025-12-16Merrill Lynch
2025-12-16Atlas Venture Fund X, LPShareholder23K$2.1M0.060%2025-12-16Merrill Lynch
2025-12-16Atlas Venture Fund X, L.P.Shareholder52K$4.8M0.138%2025-12-16BTIG, LLC
2025-12-16Atlas Venture Associates XII, L.P.Shareholder10K$915K0.026%2025-12-16BTIG, LLC
2025-12-16AI DMI LLCAffiliate40K$3.6M0.105%2025-12-16Tourmaline Partners, LLC
2025-12-15WILLIAM SAVAGEOfficer13K$1.2M0.035%2025-12-15Morgan Stanley Smith Barney LLC Executive Financial Services
2025-12-15KEVIN J BITTERMANOfficer7K$643K0.019%2025-12-15Morgan Stanley Smith Barney LLC Executive Financial Services
2025-12-15Atlas Venture Opportunity Fund II, LPShareholder8K$736K0.021%2025-12-15Merrill Lynch
2025-12-15Atlas Venture Opportunity Fund II, L.P.Shareholder9K$814K0.023%2025-12-15BTIG, LLC
2025-12-15Atlas Venture Opportunity Fund I, LPShareholder15K$1.4M0.041%2025-12-15Merrill Lynch
2025-12-15Atlas Venture Opportunity Fund I, L.P.Shareholder17K$1.6M0.046%2025-12-15BTIG, LLC
2025-12-15Atlas Venture Fund XII, LPShareholder6K$566K0.016%2025-12-15Merrill Lynch
2025-12-15Atlas Venture Fund X, LPShareholder32K$2.9M0.085%2025-12-15Merrill Lynch
2025-12-15Atlas Venture Fund X, L.P.Shareholder37K$3.4M0.098%2025-12-15BTIG, LLC
2025-12-15Atlas Venture Associates XII, L.P.Shareholder7K$629K0.018%2025-12-15BTIG, LLC
2025-12-15AI DMI LLCAffiliate6K$538K0.015%2025-12-15Tourmaline Partners, LLC
2025-12-12Atlas Venture Opportunity Fund II, LPShareholder12K$1.2M0.033%2025-12-12Merrill Lynch
2025-12-12Atlas Venture Opportunity Fund I, LPShareholder24K$2.2M0.063%2025-12-12Merrill Lynch
2025-12-12Atlas Venture Fund XII, LPShareholder9K$887K0.025%2025-12-12Merrill Lynch

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

10 holders report 5% or more of IRON in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is FMR LLC at 12.8% of the class (4,875,473 shares), filed 2026-08-06 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-10-2613D/Ano. 7Access Industries Holdings LLCother entity2.9M6.6%2026-10-22
2026-10-2613D/Ano. 7AI DMI LLCother entity2.9M6.6%2026-10-22
2026-10-2613D/Ano. 7Access Industries Management, LLCother entity2.9M6.6%2026-10-22
2026-10-2613D/Ano. 7Len Blavatnikindividual2.9M6.6%2026-10-22
2026-08-0613G/Ano. 4FMR LLCparent holding company4.9M12.8%2026-06-30
2026-08-0613G/Ano. 4Abigail P. Johnsonindividual4.9M12.8%2026-06-30
2026-01-0713GRA Capital Management, L.P.investment adviser, partnership2.2M5.9%2025-12-30
2026-01-0713GPeter Kolchinskyparent holding company, individual2.2M5.9%2025-12-30
2026-01-0713GRajeev Shahparent holding company, individual2.2M5.9%2025-12-30
2026-01-0713GRA Capital Healthcare Fund, L.P.partnership2.2M5.9%2025-12-30
2025-12-1713D/Ano. 5Atlas Venture Fund X, L.P.partnership813K2.2%2025-12-12
2025-12-1713D/Ano. 5ATLAS VENTURE ASSOCIATES X, L.P.partnership813K2.2%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates X, LLCother entity813K2.2%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates Opportunity I, LLCother entity349K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates Opportunity II, LPpartnership337K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates Opportunity II, LLCother entity337K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Opportunity Fund I, L.P.partnership349K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates Opportunity I, L.P.partnership349K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Opportunity Fund II, L.P.partnership337K0.9%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates XII, L.P.partnership14K0.0%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Fund XII, L.P.partnership14K0.0%2025-12-12
2025-12-1713D/Ano. 5Atlas Venture Associates XII, LLCother entity14K0.0%2025-12-12

13F holders

Tracked managers holding IRON at their latest 13F. JSON

5 of the 30 tracked managers held IRON at their latest 13F, $52.8M in total at quarter-end prices. Two Sigma Investments is the largest at $37.4M (0.0% of its portfolio) as of 2026-09-30. Over the prior quarter 2 added shares and 3 cut.

FundQuarterSharesValueOf portfolioChange in shares
Two Sigma Investments2026-09-30571K$37.4M0.03%+434K
Citadel Advisors2026-09-30131K$8.6M0.00%-78K
Millennium Management2026-09-3053K$3.5M0.00%-53K
D. E. Shaw & Co.2026-09-3043K$2.8M0.00%+37K
AQR Capital Management2026-09-309K$563K0.00%-1K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In FY 2025 it generated -$180.4M of operating cash flow. As of 2026-09-30, cash was $90.0M against $59.7M of debt.

Cash
$90.0M
Debt
$59.7M
Equity
$604.3M
Total assets
$699.5M
Shares outstanding
45,540,842

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q3 FY 20262026-09-30n/a-$59.5Mn/a-1.53
Q2 FY 20262026-06-30n/a-$59.5Mn/a-1.54
Q1 FY 20262026-03-31n/a-$63.5Mn/a-1.65
Q4 FY 2025derived2025-12-31n/a-$60.5Mn/an/a
Q3 FY 20252025-09-30n/a-$62.3Mn/a-1.77
Q2 FY 20252025-06-30n/a-$55.2Mn/a-1.58
Q1 FY 20252025-03-31n/a-$34.1Mn/a-1.02
Q4 FY 2024derived2024-12-31n/a-$29.5Mn/an/a

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31n/a-$212.2M-$180.4M$933Kn/an/a
FY 20242024-12-31n/a-$109.4M-$93.9M$505Kn/an/a
FY 20232023-12-31n/a-$76.4M-$73.5M$89Kn/an/a
FY 20222022-12-31n/a-$46.8M-$42.3M$151Kn/an/a
FY 20212021-12-31n/a-$36.0M-$27.5M$68Kn/an/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2026-10-29 from the cover page.

What this page is

Disc Medicine in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Disc Medicine (IRON), SEC CIK 1816736, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-20.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-30.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-11-10.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-26.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-09-30.JSON and CSV
Financials
SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-11-05.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-11-10.JSON and CSV
Company record
EDGAR filing index for CIK 1816736Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of IRON is sold short?
6,862,594 shares were held short at the 2026-10-30 settlement, 3.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is IRON's daily short volume?
On 2026-11-20, 109,251 of the 206,367 IRON shares reported to FINRA were sold short, 52.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does IRON have fails to deliver?
The SEC's latest file shows 12,952 IRON shares failed to deliver at settlement 2026-10-30. Fails are reported per settlement date and published twice a month with a lag.
Are IRON insiders buying or selling?
Insiders at IRON reported 28 open-market sells worth $11.9M in the last 90 days and no open-market buys. Latest filing: Savage William Jacob (Chief Medical Officer) on 2026-11-10.
Have IRON insiders filed to sell?
50 Form 144 notices on file for IRON worth $54.5M at the prices reported; 2 in the last 90 days worth $3.2M. Latest: WILLIAM SAVAGE filed on 2026-11-10 to sell 16,035 shares ($1.3M) from 2026-11-10.
Who owns 5% or more of IRON?
10 holders report 5% or more of IRON in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is FMR LLC at 12.8% of the class (4,875,473 shares), filed 2026-08-06 for an event on 2026-06-30.
What did IRON report last quarter?
In FY 2025 it generated -$180.4M of operating cash flow. As of 2026-09-30, cash was $90.0M against $59.7M of debt.
Which tracked 13F managers own IRON?
5 of the 30 tracked 13F managers held IRON shares at their latest filing, $52.8M in all. The largest: Two Sigma Investments (571K shares, $37.4M), Ken Griffin's Citadel Advisors (131K shares, $8.6M), Izzy Englander's Millennium Management (53K shares, $3.5M), D. E. Shaw & Co. (43K shares, $2.8M), Cliff Asness's AQR Capital Management (9K shares, $563K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.